Heron Therapeutics | HRTX - 普通股股本

金融业

USD

USD 246.22M

现金及等价物

USD 26.12M

USD 11.12M

USD 228.98M

USD 90.52M

USD 149.65M

股息收益率

0

USD 38K

USD -3.88M

126

EPS每股收益

USD -0.02

股本和储备

USD 9.14M

USD 29.47M

债务利息支出

USD 600K

USD 433K

USD 140.64M

USD 60.1M

USD -2.95M

USD 40.55M

USD 38K

普通股股本

USD 188.31M

USD -2.95M

USD 40.59M

销售和管理费用

USD 23.74M

USD 54.57M

贸易债权人

USD 8.97M

应收帐款人

USD 89.59M

	普通股股本	更改		日
ALKERMES	USD 166.46M		855K	2026-03
Alnylam Pharmaceuticals	USD 133.44M		1.07M	2026-03
Amarin	USD 20.81M		13K	2025-12
ANI Pharmaceuticals	USD 22.49M		760K	2025-12
Anika Therapeutics	USD 13.89M		532K	2025-12
Arrowhead Research	USD 137.39M		1.69M	2025-12
Eisai	JPY 282.11M		0	2026-03
Emergent BioSolutions	USD 100K		0	2023-06
Esperion Therapeutics	USD 245.22M		39.79M	2025-12
GlaxoSmithKline	GBP 4.05B		20.6M	2026-03
Heron Therapeutics	USD 188.31M		4.99M	2025-12
Insmed	USD 216.52M		2.27M	2026-03
Ligand Pharmaceuticals	USD 19.66M		19.64M	2025-09
Merck	USD 2.47B		12.72M	2025-12
Nektar Therapeutics	USD 20.38M		20.36M	2025-12
Neurocrine Biosciences	USD 100.6M		500K	2026-03
Omeros	USD 611K		17K	2023-12
Pacira	USD 39.31M		1.81M	2026-03
Regeneron Pharmaceuticals	USD 105M		300K	2026-03
Roche Holding	CHF 795.62M		699.54K	2025-12
Ultragenyx Pharmaceutical	USD 98.3M		1.7M	2026-03
Veracyte	USD 79.79M		743K	2026-03
Vertex Pharmaceuticals	USD 254.2M		200K	2026-03